Use Able AI chat for product recommendations
  • Featured Product
  • KD/KO Validated

PRKACA Monoclonal antibody

PRKACA Monoclonal Antibody for WB, IHC, ELISA

Cat No. 67491-1-Ig
Clone No. 4G10D7
Publications (9)
Review Product
Download datasheet

Host / Isotype

Mouse / IgG2a

Reactivity

human, mouse, rat, pig

Applications

WB, IHC, ELISA

4G10D7, cAMP-dependent protein kinase catalytic subunit alpha, EC:2.7.11.11, PKA C alpha, PKA C-alpha

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
PBS Only
Conjugate:  Unconjugated
Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for PRKACA in ?

Tested Applications

Positive WB detected inPC-3 cells, HeLa cells, LNCaP cells, HepG2 cells, Jurkat cells, K-562 cells, HSC-T6 cells, NIH/3T3 cells, Pig liver tissue
Positive IHC detected inhuman breast cancer tissue, human prostate cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:5000-1:50000
Immunohistochemistry (IHC)IHC : 1:500-1:2000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

67491-1-Ig targets PRKACA in WB, IHC, ELISA applications and shows reactivity with human, mouse, rat, pig samples.

Tested Reactivity human, mouse, rat, pig
Cited Reactivityhuman, mouse
Host / Isotype Mouse / IgG2a
Class Monoclonal
Type Antibody
Immunogen

CatNo: Ag26400

Product name: Recombinant human PRKACA protein

Source: e coli.-derived, PET28a

Tag: 6*His

Domain: 162-351 aa of BC039846

Sequence: DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEEEIRVSINEKCGKEFSEF

Predict reactive species
Full Name protein kinase, cAMP-dependent, catalytic, alpha
Calculated Molecular Weight 41 kDa
Observed Molecular Weight 38-43 kDa
GenBank Accession NumberBC039846
Gene Symbol PRKACA
Gene ID (NCBI) 5566
RRIDAB_2882716
Conjugate Unconjugated
FormLiquid
Purification MethodProtein A purification
UNIPROT IDP17612
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

PRKACA (protein kinase cAMP-activated catalytic subunit alpha) is a gene that encodes the catalytic subunit alpha of protein kinase A (PKA), a critical enzyme in the cyclic adenosine monophosphate (cAMP) signaling pathway. Functioning as the primary effector of cAMP, this kinase regulates a vast array of cellular processes, including metabolism, gene expression, cell cycle progression, and synaptic plasticity. Under basal conditions, the catalytic subunit is held inactive by regulatory subunits; upon cAMP binding, it is released and phosphorylates a diverse range of substrate proteins on serine and threonine residues. Beyond its physiological roles, aberrant PRKACA activity, particularly gene fusions and copy number gains, is a well-established driver of specific human diseases, most notably fibrolamellar hepatocellular carcinoma (FLC), where a characteristic DNAJB1-PRKACA fusion acts as the oncogenic driver.

Protocols

Product Specific Protocols
IHC protocol for PRKACA antibody 67491-1-IgDownload protocol
WB protocol for PRKACA antibody 67491-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

PRKACA Monoclonal antibody (4G10D7), catalog number 67491-1-Ig, has 9 total citations. These appear in journals including J Clin Invest, J Neuroinflammation, Clin Sci (Lond), CNS Neurosci Ther, Int J Mol Sci, Int Immunopharmacol, Mediators Inflamm, Cancer Med, and Eur J Histochem. Research fields span metabolic-associated steatohepatitis, neuroinflammation and synaptic pruning, gestational diabetes, spinal cord injury recovery, microglial inflammation, ovarian cAMP-PKA signaling, intestinal immunity, and cancer progression via Wnt/cAMP pathways.

SpeciesApplicationTitle
WB

J Clin Invest

Integrated screening identifies GPR31 as a key driver and druggable target for metabolic dysfunction-associated steatohepatitis

Authors - Xiao-Jing Zhang
mouseWB

J Neuroinflammation

Neural impairments caused by energy storage material NCM811 via aberrated synaptic pruning: role of Th17 cells in microglia polarization.

Authors - Cuishuang Dong
WB

Clin Sci (Lond)

Placental small extracellular vesicles from normal pregnancy and gestational diabetes increase insulin gene transcription and content in β cells.

Authors - Faheem Seedat

CNS Neurosci Ther

Transcranial iTBS Combined With Trans-Spinal iTBS Targeting PDE1A/cAMP/PKA Axis Regulates Neural Regeneration After Spinal Cord Injury

Authors - Yingxue Fu

Int J Mol Sci

Adenosine A2A Receptor Contributes to Bidirectional Remodeling of Microglial Inflammatory Responses During Methamphetamine Exposure.

Authors - Zhenping Hou
mouseWB

Int Immunopharmacol

Melatonin orchestrates cAMP-PKA signaling to alleviate zearalenone-impaired the estradiol synthesis in mammal ovary.

Authors - Qiao Li
Loading...
||
New chat

Able™

正在加载,请稍候...